The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients*
Abstract
OBJECTIVE: The role of intensive insulin therapy in medical surgical intensive care patients remains unclear. The objective of this study was to examine the effect of intensive insulin therapy on mortality in medical surgical intensive care unit patients. DESIGN: Randomized controlled trial. SETTINGS: Tertiary care intensive care unit. PATIENTS: Medical surgical intensive care unit patients with admission blood glucose of > 6.1 mmol/L or 110 mg/dL. INTERVENTION: A total of 523 patients were randomly assigned to receive intensive insulin therapy (target blood glucose 4.4-6.1 mmol/L or 80-110 mg/dL) or conventional insulin therapy (target blood glucose 10-11.1 mmol/L or 180-200 mg/dL). MEASUREMENTS AND MAIN OUTCOMES: The primary end point was intensive care unit mortality. Secondary end points included hospital mortality, intensive care unit and hospital length of stay, mechanical ventilation duration, the need for renal replacement therapy and packed red blood cells transfusion, and the rates of intensive care unit acquired infections as well as the rate of hypoglycemia (defined as blood glucose < or = 2.2 mmol/L or 40 mg/dL). There was no significant difference in intensive care unit mortality between the intensive insulin therapy and conventional insulin therapy groups (13.5% vs. 17.1%, p = 0.30). After adjustment for baseline characteristics, intensive insulin therapy was not associated with mortality difference (adjusted hazard ratio 1.09, 95% confidence interval 0.70-1.72). Hypoglycemia occurred more frequently with intensive insulin therapy (28.6% vs. 3.1% of patients; p < 0.0001 or 6.8/100 treatment days vs. 0.4/100 treatment days; p < 0.0001). There was no difference between the intensive insulin therapy and conventional insulin therapy in any of the other secondary end points. CONCLUSIONS: Intensive insulin therapy was not associated with improved survival among medical surgical intensive care unit patients and was associated with increased occurrence of hypoglycemia. Based on these results, we do not advocate universal application of intensive insulin therapy in intensive care unit patients. TRIAL REGISTRATION: Current Controlled Trials registry (ISRCTN07413772) http://www.controlled-trials.com/ISRCTN07413772/07413772; 2005.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overall rate of severe hypoglycemic events in international trials ranged between 5% to 28.6%.3,4,7,8,18,19”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [18]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664 · cited 2×
“nonoperative), history of diabetes, inclusion blood glucose, ICU admission diagnosis and the presence of chronic illnesses using APACHE II definitions (15), vasopressor therapy (defined as the use of any vasopressor infusion except dopamine 5 g/ kg/min), mechanical ventilation, serum creatinine, platelet count, biliru…”
MethodAPACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Because of concerns about trials stopped early for benefit (7), it was suggested that the potential benefits of IIT shown in surgical patients had been inflated (8), thereby causing a premature rush to adopt the therapy (2).”
BackgroundResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862 · cited 1×
“At baseline the following data were recorded: patient’s demographics, weight, height, body mass index (BMI), Acute Physiology and Chronic Health Evaluation (APACHE) II score (15), Sequential Organ Failure Assessment (SOFA) score (16), admission category (postoperative vs.”
MethodPreiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Insulin therapy protects the central and peripheral nervous system of intensive care patients
Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., & Wouters, P. J. (2005) · Neurology · doi:10.1212/01.wnl.0000158442.08857.fc · Cited by 642 · cited 1×
“found that IIT reduced ventilation dependency, intracranial pressure, seizures, and diabetes insipidus, but did not affect mortality (27).”
BackgroundBaird, T. A., Parsons, M. W., Phan, T., Butcher, K. S., Desmond, P. M., Tress, B. M., Colman, P. G., Chambers, B. R., & Davis, S. M. (2003) · Stroke · doi:10.1161/01.str.0000085087.41330.ff · Cited by 627
Gandhi, G. Y., Nuttall, G. A., Abel, M. D., Mullany, C. J., Schaff, H. V., O'Brien, P. C., Johnson, M. G., Williams, A. R., Cutshall, S. M., Mundy, L. M., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-4-200702200-00002 · Cited by 607
Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units
Van den Berghe, G., Wilmer, A., Milants, I., Wouters, P. J., Bouckaert, B., Bruyninckx, F., Bouillon, R., & Schetz, M. (2006) · Diabetes · doi:10.2337/db06-0855 · Cited by 599 · cited 2×
“(24) conducted another study to examine the effect of IIT in medical patients.”
BackgroundResultHyperglycemia After SAH: Predictors, Associated Complications, and Impact on Outcome
Frontera, J. A., Fernandez, A., Claassen, J., Schmidt, M., Schumacher, H. C., Wartenberg, K., Temes, R., Parra, A., Ostapkovich, N. D., & Mayer, S. A. (2006) · Stroke · doi:10.1161/01.str.0000194960.73883.0f · Cited by 207 · cited 1×
“Hyperglycemia has been shown to be detrimental to patients with neurologic dysfunction (25, 26), but whether intensive control of blood glucose in such patients is beneficial is yet to be clarified.”
BackgroundArabi, Y., Alshimemeri, A., & Taher, S. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000203947.60552.dd · Cited by 191
Self-citationIngels, C., Debaveye, Y., Milants, I., Buelens, E., Peeraer, A., Devriendt, Y., Vanhoutte, T., Van Damme, A., Schetz, M., Wouters, P. J., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi855 · Cited by 191 · cited 1×
“surgical study were recovering from cardiac surgery; a group that has been shown to have reduction in mortality with IIT (23).”
Intensive Insulin in Intensive Care
Malhotra, A. (2006) · New England Journal of Medicine · doi:10.1056/nejme058304 · Cited by 124 · cited 2×
“Several concerns were raised about this study because of the relatively high mortality in the control group in relation to the severity of illness, the administration of 200–300 g of intravenous glucose in the first 24 hrs, the routine early use of total parenteral nutrition, and the narrow population predominantly ma…”
BackgroundIntensive Insulin Therapy in Critical Illness
Angus, D. C., & Abraham, E. H. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2508009 · Cited by 95 · cited 2×
“Because of concerns about trials stopped early for benefit (7), it was suggested that the potential benefits of IIT shown in surgical patients had been inflated (8), thereby causing a premature rush to adopt the therapy (2).”
BackgroundLivingston, B. M., MacKenzie, S. J., MacKirdy, F. N., & Howie, J. C. (2000) · Critical Care Medicine · doi:10.1097/00003246-200002000-00017 · Cited by 80 · cited 1×
“For the latter, we used the worst GCS value for nonsedated patients and the presedation score for patients under sedation as described in the literature (17).”
MethodIntensive Insulin Therapy in Postoperative Intensive Care Unit Patients
Egi, M., Bellomo, R., Stachowski, E., French, C., Hart, G. K., Stow, P. J., Li, W., & Bates, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-961oc · Cited by 66 · cited 3×
“(21) conducted a decision analysis and found that the number needed to treat varied considerably from 35 to as high as 125.”
BackgroundGlycemic control in the ICU: a multicenter survey
Cook, D., McMullin, J., Brożek, J., Jaeschke, R., Hamielec, C. M., Dhingra, V. K., Rocker, G. M., Freitag, A. P., & Gibson, J. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2242-4 · Cited by 61 · cited 1×
“The uncertainty about the impact of IIT on the outcome of critically ill patients, the methodologic concerns in the existing studies (8) in addition to the potential risk of hypoglycemia (9) calls for the need for further studies to confirm the efficacy and safety of this therapeutic modality (10).”
BackgroundArabi, Y. M., Haddad, S. H., Sakkijha, M. H., & Shimemeri, A. A. (2004) · Nutrition in Clinical Practice · doi:10.1177/0115426504019005523 · Cited by 36 · cited 1×
“Nutrition was prescribed by the treating intensivists after a previously published protocol from our ICU (13), early in the ICU course with enteral feeding being the standard route.”
MethodSelf-citationClosed-format intensive care: Time to act now
Arabi, Y. M., Al-Shimemeri, A. A., & Taher, S. M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000234663.23581.26 · Cited by 33
Self-citationRandomized Trials Stopped Early for Benefit: A Systematic Review
Montori, V. M., Devereaux, P. J., Adhikari, N. K. J., Burns, K. E. A., Eggert, C. H., Briel, M., Lacchetti, C., Leung, T. W., Darling, E., Bryant, D. M., et al. (2005) · JAMA · doi:10.1001/jama.294.17.2203 · Cited by 26 · cited 2×
“Because of concerns about trials stopped early for benefit (7), it was suggested that the potential benefits of IIT shown in surgical patients had been inflated (8), thereby causing a premature rush to adopt the therapy (2).”
BackgroundIs it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU?
Devos, P., & Preiser, J. (2006) · Critical Care · doi:10.1186/cc4871 · Cited by 21 · cited 1×
“The uncertainty about the impact of IIT on the outcome of critically ill patients, the methodologic concerns in the existing studies (8) in addition to the potential risk of hypoglycemia (9) calls for the need for further studies to confirm the efficacy and safety of this therapeutic modality (10).”
BackgroundIntensive insulin therapy in septic shock
Orford, N. R. (2006) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)02096-3 · Cited by 16
The Highs and Lows of Intensive Insulin Therapy
Fowler, R., & Annane, D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2510006 · Cited by 14
Research works printed but not linked: 2
- Orford, 2006, Crit Care Resusc, 8, 230
- Devos, 2007, Intensive care Med, 33, S189
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Peberdy, M. A., Callaway, C. W., Neumar, R. W., Geocadin, R. G., Zimmerman, J. L., Donnino, M., Gabrielli, A., Silvers, S. M., Zaritsky, A. L., Merchant, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.971002 · Cited by 2,522
Metadata
- Authors
- Arabi, Y. M., Dabbagh, O. C., Tamim, H. M., Al-Shimemeri, A. A., Memish, Z. A., Haddad, S. H., Syed, S. J., Giridhar, H. R., Rishu, A. H., Al-Daker, M. O., Kahoul, S. H., Britts, R. J., & Sakkijha, M. H.
- Affiliations
- King Saud bin Abdulaziz University for Health Sciences (SA)
- Venue
- Critical Care Medicine
- Published
- 2008-12
- Volume
- 36
- Issue
- 12
- Pages
- 3190-3197
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2058406121
- Cited by
- 471
- References
- 27
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 14 · 2023: 7 · 2022: 3 · 2021: 12 · 2020: 19 · 2019: 21 · 2018: 23 · 2017: 23 · 2016: 32 · 2015: 39 · 2014: 25 · 2013: 28 · 2012: 41
- FWCI
- 40.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, conventional insulin therapy, glycemic control, critically ill patients, ICU mortality, hypoglycemia, glycemic targets, mechanical ventilation, renal replacement therapy, intensive care unit infections, length of hospital stay, hyperglycemia, sepsis, trauma, neurocritical care
- MeSH terms
- Blood Glucose, Body Weights and Measures, Demography, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Length of Stay, Male, Middle Aged, Postoperative Period, Respiration, Artificial, Surgical Procedures, Operative, Critical Illness, Hospital Mortality, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.